Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GenomeDx Decipher Test for Metastatic Disease in Prostate Cancer for Patients With Adverse Pathology Post Radical Prostatectomy: Does it Impact Physician Decision Making?

NCT02020876 is registered in ClinicalTrials.gov with GenomeDx Biosciences Corp as lead sponsor.

NCT NCT02020876
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02020876 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GenomeDx Decipher Test for Metastatic Disease in Prostate Cancer for Patients With Adverse Pathology Post Radical Prostatectomy: Does it Impact Physician Decision Making?
Lead sponsor
GenomeDx Biosciences Corp
Phase
Observational
Overall status
Completed
Start date
August 31, 2012
Completion date
December 31, 2013
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer